SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
Dr.Lyo
Lv4
490 积分
2023-06-25 加入
最近求助
最近应助
互助留言
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
8天前
已完结
Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges
13天前
已完结
Acquired resistance mechanisms to osimertinib: The constant battle
13天前
已完结
Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies
13天前
已完结
Targeted therapy for rare lung cancers: Status, challenges, and prospects
13天前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
13天前
已完结
Emerging Strategies for the Treatment of Small Cell Lung Cancer
13天前
已完结
Advancements in small cell lung cancer
13天前
已完结
Adjuvant Treatments for Surgically Resected Non–Small Cell Lung Cancer Harboring EGFR Mutations
13天前
已完结
Perioperative Immune Checkpoint Inhibition in Early-Stage Non–Small Cell Lung Cancer
13天前
已完结
没有进行任何应助
感谢,感谢
8天前
感谢,感谢,感谢
13天前
感谢,感谢,感谢
13天前
感谢,感谢,感谢
13天前
感谢,感谢,感谢,感谢
13天前
感谢,感谢
13天前
感谢,感谢,感谢,感谢,感谢,感谢
13天前
能下个正式版吗? 这个proof的 Figure 2 看不清
13天前
感谢,感谢
13天前
感谢,感谢,感谢,感谢
13天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论